Federal Government
-
Federal Government Announces Research Grants For Preventing Violence & Violence Related Injury (R01) Funding
RFP | August 31, 2023 -
Federal Government Announces Scalable & Systematic Neurobiology Of Psychiatric & Neurodevelopmental Disorder Risk Genes: Assay & Data Generation Centers (RM1 Clinical Trial Not Allowed) Grant Funding
RFP | August 31, 2023 -
Federal Government Announces Research Grants To Identify Effective Community-Based Strategies For Overdose Prevention (R01) Funding
RFP | August 31, 2023 -
Federal Government Announces Grants To Support New Investigators In Conducting Research Related To Preventing Interpersonal Violence Impacting Children & Youth Funding
RFP | August 31, 2023 -
Federal Government Announces Early-Stage Biomedical Data Repositories & Knowledgebases (R24 Clinical Trial Not Allowed) Grant Funding
RFP | August 31, 2023 -
Federal Government Announces Rigorous Evaluation Of Policy-Level Interventions To Prevent Overdose (R01) Grant Funding
RFP | August 31, 2023 -
Federal Government Announces Grants To Support New Investigators In Conducting Research Related To Understanding Drug Use & Overdose Risk & Protective Factors (K01) Funding
RFP | August 31, 2023 -
Federal Government Announces Enhancement & Management Of Established Biomedical Data Repositories & Knowledgebases (U24 Clinical Trial Not Allowed) Grant Funding
RFP | August 31, 2023 -
Federal Government Announces Diagnostic Centers Of Excellence For The Undiagnosed Diseases Network (U01 Clinical Trial Not Allowed) Grant Funding
RFP | August 31, 2023 -
Federal Government Announces Developing Salivary Components As Therapeutics For Oral Health (R01 Clinical Trial Not Allowed) Grant Funding
RFP | August 30, 2023 -
Federal Government Announces Developing Salivary Components As Therapeutics For Oral Health (R21 Clinical Trial Not Allowed) Exploratory/Developmental Research Grant Funding
RFP | August 30, 2023 -
Federal Government Announces Research Tools For Difficult To Culture Eukaryotic Pathogens (R61/R33 Clinical Trial Not Allowed) Grant Funding
RFP | August 30, 2023 -
Federal Government Announces Biotypes Of CNS Complications In People Living With HIV (P01 Clinical Trial Not Allowed) Grant Funding
RFP | August 30, 2023 -
Federal Government Announces Initiative To Maximize Research Education In Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed) Grant Funding
RFP | August 30, 2023 -
Federal Government Announces Collaborative Science To Achieve Disruptive Innovations In Dental, Oral & Craniofacial (DOC) Research (RM1 Clinical Trial Not Allowed) Grant Funding
RFP | August 29, 2023 -
Federal Government Announces Broadening Opportunities For Computational Genomics & Data Science Education (UE5 – Clinical Trial Not Allowed) Grant Funding
RFP | August 29, 2023 -
Federal Government Announces Building Neuroscience Research Infrastructure For Alzheimer’s Disease (AD) & AD-Related Dementias (ADRD) In Africa (UG3/UH3 Clinical Trial Not Allowed) Grant Funding
RFP | August 28, 2023 -
Federal Government Announces Improving Choice, Use & Equitable Implementation Of Biomedical HIV Prevention For Women (R34 Clinical Trial Optional) Planning Grant Funding
RFP | August 25, 2023 -
Federal Government Announces Population Assessment Of Tobacco & Health (PATH) Study Biospecimen Access (X01) Grant Funding
RFP | August 25, 2023 -
Federal Government Announces Improving Choice, Use & Equitable Implementation Of Biomedical HIV Prevention For Women (R21 Clinical Trial Optional) Exploratory/Developmental Research Grant Funding
RFP | August 25, 2023 -
Federal Government Announces Improving Choice, Use & Equitable Implementation Of Biomedical HIV Prevention For Women (R01 Clinical Trial Optional) Grant Funding
RFP | August 25, 2023 -
Federal Government Announces Chimeric Antigen Receptor (CAR) Approaches To AD/ADRD (R61/R33 Clinical Trial Not Allowed) Grant Funding
RFP | August 24, 2023 -
Federal Government Announces Seamless Early-Stage Clinical Drug Development (Phase 1 To 2a) For Novel Therapeutic Agents For The Spectrum Of Alzheimer’s Disease (AD) & AD-Related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) Grant Funding
RFP | August 24, 2023 -
Making Care Primary, Request For Applications
Market Intelligence Resource | August 23, 2023 -
Federal Government Announces Mechanisms That Impact Cancer Risk With Use Of Incretin Mimetics (R01 Clinical Trial Optional) Grant Funding
RFP | August 23, 2023